Ligand Pharmaceuticals, Inc. (LGND)

227.31 -2.14 (-0.93%) USD  |  NASDAQ  |  May 01, 16:00
227.43 +0.12 (+0.05%) Pre-Market: 20:00
More

Ligand Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for LGND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
XOMA Royalty Corp. Upgrade
Amicus Therapeutics, Inc. Upgrade
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Travere Therapeutics, Inc. Upgrade